Per-Henrik Groop - Articles and news items

Boehringer Ingelheim logo
Novartis logo

Novartis drug Galvus® approved in EU

Industry news, News / 5 December 2011 / Novartis

The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...